Back
Sypris Solutions Vs. Blueprint Medicines Industry Stock Comparison
Sell
50
SYPR
Sypris Solutions
Last Price:
$2.23
Seasonality Move:
5.16%
Sell
50
BPMC
Blueprint Medicines
Last Price:
$128.39
Seasonality Move:
6.28%
Sell
50
Sypris Solutions (SYPR)
is a Sell
Is Sypris Solutions a Buy, Sell or Hold?
-
The current Sypris Solutions [SYPR] share price is $2.19. The Score for SYPR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
SYPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $128.35. The Score for BPMC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SYPR Stock Price Chart
What is Sypris Solutions's stock price today?
-
The Sypris Solutions share price today is $2.19Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYPR is experiencing slight selling pressure.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $128.35Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.
SYPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.08 | Buy |
Relative Strength Index (14 RSI): | 57.22 | Buy |
Chaikin Money Flow: | -7356 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.95 - 2.15) | Buy |
Bollinger Bands (100): | (1.58 - 2.02) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.65 | Buy |
Relative Strength Index (14 RSI): | 74.59 | Buy |
Chaikin Money Flow: | 675123 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (119 - 133.06) | Buy |
Bollinger Bands (100): | (84.56 - 117) | Buy |
SYPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.14 | Buy |
20-day SMA: | 2.07 | Buy |
50-day SMA: | 1.86 | Buy |
200-day SMA: | 1.76 | Buy |
8-day EMA: | 2.13 | Buy |
20-day EMA: | 2.06 | Buy |
50-day EMA: | 1.93 | Buy |
200-day EMA: | 1.81 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 128.23 | Buy |
20-day SMA: | 128.14 | Buy |
50-day SMA: | 111.57 | Buy |
200-day SMA: | 97.6 | Buy |
8-day EMA: | 128.16 | Buy |
20-day EMA: | 125.23 | Buy |
50-day EMA: | 115.07 | Buy |
200-day EMA: | 100.77 | Buy |
Sypris Solutions Earnings Growth & SYPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.
Sypris Solutions Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |